Poziotinib

A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer

A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants

A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway

Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer

Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)

Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib

Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations